Sign in
Protocol U: Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involv
Raj K. Maturi, MD
Updates from the Field
2017
2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)
Nancy M. Holekamp, MD, FASRS
Annual Meeting Talks
2018
Episode 16: PLACE Trial: Half-Dose PDT vs Micropulse Laser for Central Serous Chorioretinopathy with Dr. Camiel Boon
Keyvan Koushan, MD, FRCSC
Member Podcasts
Category: Diabetic Retinopathy